Global
Businesses

Crisplus

Obesity peripheral action treatment. Indicated for the treatment and long-term control of patients with obesity and overweight.

Therapeutic Area
Obesity

Active Ingredient
Orlistat

Line
Cardiometabolism + Endocrinology

Pharmaceutical Forms
60 mg capsules x 30
60 mg capsules x 60
120 mg capsules x 30
120 mg capsules x60

Download Leaflet
Crisplus 60mg
Crisplus 120mg